Skip to content
Recall Observatory FDA recall evidence

Device product

Azurion systems with software release R2.0.x

Z-0734-2022

May 26, 2021

Class II

Product summary

Firm
Philips Healthcare
Event
Event 89742
Status
Completed
Classification
Class II
Quantity
69 systems
Official record key
device-enforcement:Z-0734-2022

Official wording

Reason: In the Azurion system, the user can add a new study to a patient by selecting the option "Add Study". The Add Study dialogue box is then displayed where the Patient Type is selected to perform the study. Due to a software defect, when the study is initiated by pressing Start Procedure , the Patient Type changes inadvertently to a Patient Type different than the one selected as shown in the Table below. Patient type is one of the factors involved in the dose control process. The incorrect patient type changes the technique factors to be used by the system without notification to the user.

Code information: Model(s) Azurion R2.1

Distribution pattern: US Nationwide Distribution

Derived failure modes

  • Device software or design

    reason.device_software_design · v1.0.0

    software defect